Favipiravir
-
Bal Pharma launches antiviral drug Favipiravir
The formulation would be available in tablet form with 400 mg strength Bal Pharma has launched the antiviral drug Favipiravir…
Read More » -
FDC launches stronger versions of Favipiravir in India
These prescription-only drugs will be available at all retail medical outlets and hospital pharmacies across the country Drug firm FDC…
Read More » -
BDR Receives DCGI Approval for the Launch of Favipiravir to Treat COVID-19 in India
Mumbai : BDR Pharmaceuticals today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma…
Read More » -
Dr. Reddy’s, FUJIFILM and Global Response Aid partner for Potential Treatment of COVID-19
Hyderabad: Dr. Reddy’s Laboratories signed a tripartite agreement with FUJIFILM Corporation through FUJIFILM Toyama Chemical and Global Response Aid for…
Read More » -
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Mumbai: Glenmark Pharmaceuticals, has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval…
Read More »